LifeLabs has partnered with Natera, Inc. to offer SignateraTM, a molecular residual disease test that detects and monitors cancer status by examining an individual’s unique tumour genetic profile.

Client Notice: Recent evidence has emerged that suggests a reassessment of the formula for calculating estimated glomerular filtration rate (eGFR) may be in order.

Due to issues with our referral laboratory, Free Valproic Acid will temporarily be unavailable. We apologize for the inconvenience.

**Update on Testing**

Due to issues with our referral laboratory, LP-PLA2 Activity will temporarily be unavailable. We apologize for the inconvenience.

**Update on Testing**

Due to issues with our referral laboratory, LP-PLA2 Activity will temporarily be unavailable. We apologize for the inconvenience.

LL #28581-  BD LAVENDER TUBE 13X75 LAVENDER 4.0ML HEMOGARD, PLASTIC, (BD item #367861) 100/SP LL #28642 - BD GOLD TUBE 13x100 GOLD 5 0ML HEMOGARD PLASTIC 0268397 (BD item #367986) 100/SP

The referral laboratory where LifeLabs sends Copeptin testing to will discontinue parallel Osmolality testing due to concerns about pre-analytical factors affecting accuracy of osmolality results. This will go into effect on Dec 16, 2021. The reports will continue to provide comments that can be use...

As part of a large process and quality improvement initiative around our referred out testing program, a selection of referred out tests will be changing test locations over the coming months. On December 5th, 2021, a number of tests will be performed at UHN (University Health Network). This may res...

**Discontinuation of Tests** URINE BILIRUBIN AND UROBILINOGEN will be discontinued as of June 14, 2021. Please request serum liver function test(s) instead, as clinically appropriate (including ALT, AST, GGT and/or Total Bilirubin).

**Update on Turn Around Times** Due to supplier issues, we are currently experiencing a delay in turnaround time for ANGIOTENSIN CONVERTING ENZYME testing. We apologize for the inconvenience.

On March 3rd 2021, LifeLabs sent a memo to all clients informing them of a positive bias on the serum creatinine assay, causing a positive shift of up to 8 umol/L in creatinine results, along with the concurrent negative shift in eGFR. The root cause was the manufacturer reagent lot bias. An interpr...

FastTRK is a clinical testing program for the diagnosis of NTRK gene fusions. Funded by Bayer Inc., this is a complimentary service for clinicians to determine whether their patients’ cancer has an NTRK gene fusion.

Effective April 4th, 2021 LifeLabs will introduce a new methodology for C- Reactive Protein (CRP) testing. The new method shows improved accuracy and precision across the CRP clinical range, including low concentrations used in cardiovascular disease assessment and high concentrations important for ...

Effective Mar 01, 2021, LifeLabs will be performing vitamin A and E testing in-house.

PLASMA CATECHOLAMINES testing has returned to routine turn-around times. We apologize for any inconvenience.

Due to pandemic related resource re-allocation at our referral laboratory, we are currently experiencing a delay in turnaround time for OSTEOCALCIN testing. We apologize for the inconvenience.

Attention Health Care Practitioners: Please ensure patients with Standing Orders have a request that is < 6months old. Standing orders are only valid for a 6-month period. Expired Standing Orders will be rejected and the patient turned away.

IMPROVEMENTS TO my results™ PORTAL – LIFELABS PARTNERING WITH LAB TESTS ONLINE TO HELP PATIENTS LEARN ABOUT DIAGNOSTIC TESTING

Please note that iLabLink being retired on January 31st, 2020

We have received notice from our Supplier, Fisher Edmonton, to quarantine the following supplies IMMEDIATELY:

Due to supply issues, we are currently experiencing a delay in turnaround time for SELENIUM (SERUM) testing. We apologize for the inconvenience.